
Taro Pharmaceutical Industries Ltd. – NYSE:TARO
Taro Pharmaceutical Industries Ltd. stock price monthly change
Taro Pharmaceutical Industries Ltd. stock price quarterly change
Taro Pharmaceutical Industries Ltd. stock price yearly change
Taro Pharmaceutical Industries Ltd. key metrics
Market Cap | 1.61B |
Enterprise value | N/A |
P/E | 14.36 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 1.64 |
Price/Book | 0.55 |
PEG ratio | 0.12 |
EPS | 2.01 |
Revenue | 593.77M |
EBITDA | 90.55M |
Income | 75.70M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 11.41% |
Oper. margin | 11.49% |
Gross margin | 49.52% |
EBIT margin | 11.49% |
EBITDA margin | 15.25% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTaro Pharmaceutical Industries Ltd. stock price history
Taro Pharmaceutical Industries Ltd. stock forecast
Taro Pharmaceutical Industries Ltd. financial statements
Dec 2021 | 138.98M | 26.31M | 18.93% |
---|---|---|---|
Mar 2022 | 143.26M | 27.40M | 19.13% |
Mar 2023 | 146.58M | 6.91M | 4.72% |
Mar 2024 | 164.94M | 15.07M | 9.14% |
Sep 2022 | 2107279000 | 400.99M | 19.03% |
---|---|---|---|
Dec 2022 | 2117524000 | 397.58M | 18.78% |
Mar 2023 | 2135513000 | 404.65M | 18.95% |
Mar 2024 | 2162069000 | 369.06M | 17.07% |
Dec 2021 | -191.93M | -14.02M | 0 |
---|---|---|---|
Mar 2022 | 41.25M | -108.60M | 0 |
Mar 2023 | 56.65M | 6.67M | 0 |
Mar 2024 | 44.24M | -52.32M | 0 |
Taro Pharmaceutical Industries Ltd. alternative data
Aug 2023 | 1,554 |
---|---|
Sep 2023 | 1,554 |
Oct 2023 | 1,554 |
Nov 2023 | 1,554 |
Dec 2023 | 1,554 |
Jan 2024 | 1,554 |
Feb 2024 | 1,554 |
Mar 2024 | 1,554 |
Apr 2024 | 1,554 |
May 2024 | 1,554 |
Jun 2024 | 1,554 |
Jul 2024 | 1,554 |
Taro Pharmaceutical Industries Ltd. other data
Period | Buy | Sel |
---|---|---|
Sep 2010 | 2437919 | 0 |
Oct 2010 | 2333922 | 0 |
Nov 2010 | 5159765 | 5159765 |
Patent |
---|
Application Filling date: 6 Mar 2020 Issue date: 10 Feb 2022 |
Application Filling date: 29 Sep 2021 Issue date: 20 Jan 2022 |
Application Filling date: 2 Aug 2021 Issue date: 23 Dec 2021 |
Grant Utility: Topical Montelukast formulations Filling date: 2 Feb 2021 Issue date: 16 Nov 2021 |
Application Filling date: 2 Feb 2021 Issue date: 5 Aug 2021 |
Application Filling date: 18 Jan 2019 Issue date: 25 Feb 2021 |
Application Filling date: 9 Jan 2020 Issue date: 30 Jul 2020 |
Grant Filling date: 3 May 2017 Issue date: 4 Feb 2020 |
Application Filling date: 30 Aug 2017 Issue date: 31 Oct 2019 |
Quarter | Transcript |
---|---|
Q2 2021 29 Oct 2020 | Q2 2021 Earnings Call Transcript |
Q4 2020 20 May 2020 | Q4 2020 Earnings Call Transcript |
Q2 2020 5 Nov 2019 | Q2 2020 Earnings Call Transcript |
Q4 2019 23 May 2019 | Q4 2019 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Ara Aprahamian (1968) Vice President of Sales & Marketing | $616,140 |
-
When is Taro Pharmaceutical Industries Ltd.'s next earnings date?
Unfortunately, Taro Pharmaceutical Industries Ltd.'s (TARO) next earnings date is currently unknown.
-
Does Taro Pharmaceutical Industries Ltd. pay dividends?
No, Taro Pharmaceutical Industries Ltd. does not pay dividends.
-
How much money does Taro Pharmaceutical Industries Ltd. make?
Taro Pharmaceutical Industries Ltd. has a market capitalization of 1.61B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.81% to 629.18M US dollars.
-
What is Taro Pharmaceutical Industries Ltd.'s stock symbol?
Taro Pharmaceutical Industries Ltd. is traded on the NYSE under the ticker symbol "TARO".
-
What is Taro Pharmaceutical Industries Ltd.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Taro Pharmaceutical Industries Ltd.?
Shares of Taro Pharmaceutical Industries Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Taro Pharmaceutical Industries Ltd.'s key executives?
Taro Pharmaceutical Industries Ltd.'s management team includes the following people:
- Mr. Ara Aprahamian Vice President of Sales & Marketing(age: 57, pay: $616,140)
-
How many employees does Taro Pharmaceutical Industries Ltd. have?
As Jul 2024, Taro Pharmaceutical Industries Ltd. employs 1,554 workers.
-
When Taro Pharmaceutical Industries Ltd. went public?
Taro Pharmaceutical Industries Ltd. is publicly traded company for more then 42 years since IPO on 14 Sep 1982.
-
What is Taro Pharmaceutical Industries Ltd.'s official website?
The official website for Taro Pharmaceutical Industries Ltd. is taro.com.
-
How can i contact Taro Pharmaceutical Industries Ltd.?
Taro Pharmaceutical Industries Ltd. can be reached via phone at +972 4 847 5700.
Taro Pharmaceutical Industries Ltd. company profile:

Taro Pharmaceutical Industries Ltd.
taro.comNYSE
1,554
Drug Manufacturers - Specialty & Generic
Healthcare
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Haifa, 2624761
CIK: 0000906338
ISIN: IL0010827181
CUSIP: M8737E108